Neuropsychologic testing for chemotherapy-related cognitive impairment.
No standard has been established for neuropsychologic testing to identify and quantify chemotherapy-related cognitive impairment (CRCI). A number of issues exist related to the complexity of the phenomenon and lack of correlation between standardized objective tests and subjective tests by patient self-report. Review of the issues related to current neuropsychologic tests used to evaluate CRCI provides support for qualitative examination of patients' lived experience in order to guide the development of more accurate tests.
Myers
Jamie S
JS
University of Kansas School of Nursing, Kansas City 66160, USA. jamyers@swbell.net
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D009483:Neuropsychological Tests
D000970:Antineoplastic Agents